Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 10, 2024, titled "Press Release on Unaudited Financial Results of the Company for the first quarter ended June 30, 2024.".
Press Release Aug 10 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aurobindo Pharma
- Press Release Aug 06 2024
- Annual Report 2023-24
- Q1FY25
- Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray
- Press Release May 25 2024
Later from Aurobindo Pharma
- Press Release Oct 01 2024
- Press Release Oct 29 2024
- Q2FY25
- Press Release Nov 09 2024
- Q2 UFR 2024 25 Corrigendum in Consolidated UFR
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma